Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Cancel Anytime
Enjoy Unlimited Digital Access
Canada’s most-awarded
newsroom for a reason
Stay informed for a
lot less, cancel anytime
“Exemplary reporting on
COVID-19” – Herman L
$1.99
per week
for 24 weeks
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Bereaved family members take part in a photoshoot organized by Moms Stop The Harm in Mission, B.C., to raise awareness about the overdose epidemic.

Maggie MacPherson/The Globe and Mail

Sophie Breen suffered through trauma and mental illness and pursued a degree in social work. She died at 27. Nick Crazy Bull was a musician and a gamer. He died at 19. Christopher Martin worked as a mine millwright. He died at 40.

Ms. Breen, Mr. Crazy Bull and Mr. Martin are three names on a list that is far too long and getting longer every day – the toll of Canada’s overdose epidemic. Overdoses have killed more than 20,000 Canadians since 2016. Last weekend, The Globe and Mail presented the stories of 100 people who were lost in 2020 to overdoses, because last year was Canada’s worst year yet.

Most governments in Canada have been too slow to respond to an epidemic that shows no signs of abating. There are no magic solutions and no single policy that can instantly reverse the tide, but health experts have long advocated for changes such as drug decriminalization and access to a safer supply of drugs as two important measures that could save lives.

Story continues below advertisement

The severity of the epidemic has led to a shift in recent months. Many political leaders previously rejected policies such as decriminalization and safer supply, but the ideas are now, to a growing extent, embraced. The debate is no longer stuck on whether an idea is worth trying. It is more and more about how best to do it.

In late January, Health Canada agreed to formal talks with the City of Vancouver to decriminalize drugs within municipal borders. The next step is figuring out how that will work. Police in Vancouver already rarely charge people for simple possession, but backers of the move to make it official argue it would be a valuable step to ease the stigma around drug use and help people get services and treatment. It marks a fundamental shift in drug addiction, from a question of criminal justice to one of health care.

The details will matter. (And decriminalization of simple possession is not legalization of sale or trafficking.) Replacing arrests with other forms of police oversight would be a half-step, yet that is what is in the Trudeau government’s new Bill C-22, tabled on Thursday. The bill doesn’t go all the way to decriminalization; instead, it would only require police and prosecutors to “consider” alternatives to criminal charges for simple drug possession, such as treatment programs, warnings, or no action at all. Such flexibility is better than none, but if drug addiction is a health issue, it does not make sense for police to be the front-line arbiters.

In any case, decriminalization, however useful it may be, does not address what’s killing people: a poisoned supply of drugs on the street, laced with ever more amounts of fentanyl. This is where so-called “safe supply” comes in – providing prescription pharmaceuticals to people stuck in addiction as an alternative to street drugs.

Last year, Ottawa adjusted its rules and urged provinces to act. The federal government has invested $44-million in programs from B.C. to New Brunswick. A recent study in Vancouver showed a safer supply can reduce use of street drugs and risk of overdose, and regular contact with doctors and nurses can deliver other health benefits, such as addressing physical injuries for people who are often living rough.

The mechanics of safe supply are coming to the fore. B.C. has been training a group of registered nurses so they can write prescriptions, in an effort to broaden access. What sort of drugs are available is also being finalized. As these programs become more common, there are important debates among policy makers about how such drugs are best administered, to avoid creating new harms – such as the resale of provided drugs.

Harm-reduction policies are inherently pragmatic, and inherently imperfect. The ultimate goal is treatment that breaks the cycle of addiction, but long-term substance-use disorders are not easily ended in some 30-day stint in a recovery bed. Relapse is common and relapse is too often the circumstance of a deadly overdose.

Story continues below advertisement

In the gap between hoped-for better outcomes and the current grim reality, moves to expand harm reduction make sense. Previous innovations, including supervised consumption sites, have been shown to save lives. Decriminalization and safe supply are two more policy tools worth trying in the fight against a terrible epidemic. The list of overdose deaths does not need to get longer to make the urgency to act more obvious.

Keep your Opinions sharp and informed. Get the Opinion newsletter. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies